Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Founded in 2004, Penumbra has grown into a global healthcare company specializing in innovative therapies. With over 4000 employees, the company offers products in more than 100 markets worldwide....
Piper Sandler reissued their overweight rating on shares of Penumbra (NYSE:PEN – Free Report) in a report published on Friday, Benzinga reports. Piper Sandler currently has a $290.00 price target on the stock, down from their prior price target of $310.00. A number of other brokerages also recently weighed in on PEN. Morgan Stanley decreased […]
JPMorgan Chase & Co. cut shares of Penumbra (NYSE:PEN – Free Report) from an overweight rating to a neutral rating in a research report released on Friday morning, Marketbeat Ratings reports. The brokerage currently has $250.00 price objective on the stock, down from their previous price objective of $284.00. Several other brokerages have also recently […]
Penumbra (NYSE:PEN – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.05, Briefing.com reports. The firm had revenue of $284.68 million for the quarter, compared to the consensus estimate of $286.62 million. Penumbra had a […]
Fmr LLC lessened its holdings in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,016,984 shares of the company’s stock after selling 32,197 shares during the quarter. Fmr LLC […]